 Danielle Loeb
Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physicians, Primary Care | 6 | 2019 | 222 | 1.930 |
Why?
| | Primary Health Care | 10 | 2022 | 1512 | 1.800 |
Why?
| | Mental Disorders | 5 | 2019 | 892 | 1.660 |
Why?
| | Patient Care Team | 5 | 2019 | 517 | 1.590 |
Why?
| | Attitude of Health Personnel | 4 | 2017 | 975 | 1.230 |
Why?
| | Mental Health Services | 3 | 2019 | 317 | 1.090 |
Why?
| | Self Efficacy | 3 | 2019 | 355 | 1.030 |
Why?
| | Antidepressive Agents | 2 | 2017 | 195 | 0.890 |
Why?
| | Chronic Disease | 4 | 2019 | 1578 | 0.720 |
Why?
| | Medical History Taking | 2 | 2011 | 114 | 0.710 |
Why?
| | Pharmacy Service, Hospital | 2 | 2019 | 83 | 0.710 |
Why?
| | Depression | 4 | 2019 | 1133 | 0.700 |
Why?
| | Internal Medicine | 2 | 2014 | 211 | 0.700 |
Why?
| | Stakeholder Participation | 1 | 2019 | 73 | 0.630 |
Why?
| | Health Plan Implementation | 1 | 2019 | 132 | 0.620 |
Why?
| | Sexual Behavior | 2 | 2011 | 440 | 0.550 |
Why?
| | General Practice | 1 | 2016 | 27 | 0.540 |
Why?
| | Quality Improvement | 2 | 2019 | 950 | 0.460 |
Why?
| | Physician-Patient Relations | 3 | 2016 | 462 | 0.460 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 757 | 0.460 |
Why?
| | Surveys and Questionnaires | 6 | 2019 | 4620 | 0.440 |
Why?
| | Comorbidity | 2 | 2015 | 1448 | 0.440 |
Why?
| | Perception | 2 | 2015 | 311 | 0.440 |
Why?
| | Psychometrics | 1 | 2016 | 608 | 0.430 |
Why?
| | Disease Management | 1 | 2016 | 560 | 0.420 |
Why?
| | Ambulatory Care Facilities | 1 | 2014 | 213 | 0.400 |
Why?
| | Communication | 1 | 2017 | 744 | 0.400 |
Why?
| | Internship and Residency | 2 | 2011 | 926 | 0.380 |
Why?
| | Psychotherapy | 1 | 2012 | 149 | 0.370 |
Why?
| | Adult | 12 | 2022 | 30528 | 0.350 |
Why?
| | Depressive Disorder | 1 | 2012 | 332 | 0.330 |
Why?
| | Telemedicine | 1 | 2017 | 662 | 0.330 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1183 | 0.330 |
Why?
| | Documentation | 1 | 2011 | 167 | 0.330 |
Why?
| | Electronic Health Records | 2 | 2018 | 800 | 0.310 |
Why?
| | Focus Groups | 2 | 2019 | 383 | 0.290 |
Why?
| | Ambulatory Care | 1 | 2011 | 478 | 0.290 |
Why?
| | Physicians | 2 | 2016 | 772 | 0.290 |
Why?
| | Middle Aged | 11 | 2017 | 26719 | 0.280 |
Why?
| | Male | 14 | 2019 | 55554 | 0.250 |
Why?
| | Pharmacists | 2 | 2019 | 233 | 0.250 |
Why?
| | Female | 13 | 2019 | 59466 | 0.240 |
Why?
| | Practice Patterns, Physicians' | 1 | 2012 | 1177 | 0.230 |
Why?
| | Cross-Sectional Studies | 5 | 2022 | 4405 | 0.230 |
Why?
| | Colorado | 3 | 2019 | 4099 | 0.230 |
Why?
| | Interviews as Topic | 2 | 2016 | 582 | 0.220 |
Why?
| | Humans | 19 | 2022 | 114623 | 0.220 |
Why?
| | Hypertension | 3 | 2022 | 1056 | 0.200 |
Why?
| | Qualitative Research | 2 | 2016 | 934 | 0.180 |
Why?
| | Patient Preference | 1 | 2022 | 167 | 0.170 |
Why?
| | Transgender Persons | 1 | 2022 | 134 | 0.170 |
Why?
| | Southwestern United States | 1 | 2019 | 91 | 0.170 |
Why?
| | Urban Health Services | 1 | 2019 | 60 | 0.170 |
Why?
| | Retrospective Studies | 5 | 2019 | 12542 | 0.160 |
Why?
| | Logistic Models | 2 | 2014 | 1840 | 0.150 |
Why?
| | Health Personnel | 2 | 2019 | 574 | 0.140 |
Why?
| | Program Development | 1 | 2018 | 341 | 0.130 |
Why?
| | Prevalence | 1 | 2022 | 2249 | 0.130 |
Why?
| | Benzodiazepines | 1 | 2016 | 116 | 0.130 |
Why?
| | Aged | 6 | 2017 | 19061 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2019 | 632 | 0.120 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 233 | 0.110 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 40 | 0.100 |
Why?
| | Decision Support Systems, Clinical | 1 | 2014 | 176 | 0.100 |
Why?
| | Quality of Health Care | 1 | 2016 | 573 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 473 | 0.090 |
Why?
| | Registries | 1 | 2018 | 1767 | 0.090 |
Why?
| | Professional-Patient Relations | 1 | 2012 | 141 | 0.090 |
Why?
| | Anxiety | 1 | 2016 | 840 | 0.090 |
Why?
| | Dietary Fats | 1 | 2012 | 287 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2762 | 0.080 |
Why?
| | Sexually Transmitted Diseases | 1 | 2011 | 155 | 0.080 |
Why?
| | Counseling | 1 | 2012 | 342 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 2094 | 0.080 |
Why?
| | Intestinal Neoplasms | 1 | 2009 | 24 | 0.080 |
Why?
| | Lymphoma, T-Cell | 1 | 2009 | 21 | 0.080 |
Why?
| | Adolescent | 4 | 2022 | 17831 | 0.080 |
Why?
| | Academic Medical Centers | 1 | 2010 | 410 | 0.070 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 607 | 0.070 |
Why?
| | Killer Cells, Natural | 1 | 2009 | 380 | 0.060 |
Why?
| | Curriculum | 1 | 2010 | 819 | 0.060 |
Why?
| | United States | 3 | 2018 | 12176 | 0.050 |
Why?
| | Testosterone Congeners | 1 | 2022 | 7 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2012 | 6344 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2022 | 188 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 1727 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 1945 | 0.040 |
Why?
| | Estradiol | 1 | 2022 | 455 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 343 | 0.040 |
Why?
| | Pharmacies | 1 | 2019 | 32 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 471 | 0.040 |
Why?
| | Behavior | 1 | 2019 | 92 | 0.040 |
Why?
| | Pharmaceutical Services | 1 | 2019 | 77 | 0.040 |
Why?
| | Medication Therapy Management | 1 | 2019 | 67 | 0.040 |
Why?
| | Professional Role | 1 | 2019 | 149 | 0.040 |
Why?
| | Models, Organizational | 1 | 2018 | 140 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2016 | 56 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 10455 | 0.030 |
Why?
| | Chronic Pain | 1 | 2019 | 210 | 0.030 |
Why?
| | Dietary Carbohydrates | 1 | 2012 | 138 | 0.020 |
Why?
| | Health Expenditures | 1 | 2012 | 171 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2507 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2012 | 539 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 4894 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2009 | 284 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 274 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1077 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2012 | 490 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 1715 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2009 | 383 | 0.020 |
Why?
| | Antigens, CD | 1 | 2009 | 442 | 0.020 |
Why?
| | Celiac Disease | 1 | 2009 | 264 | 0.020 |
Why?
| | Prospective Studies | 1 | 2016 | 6217 | 0.020 |
Why?
| | Age Factors | 1 | 2012 | 2894 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2009 | 1342 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 1040 | 0.010 |
Why?
| | Risk Factors | 1 | 2012 | 8628 | 0.010 |
Why?
|
|
Loeb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|